Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.006 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.007 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.15 | 0.008 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.009 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.009 |
mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |